Tech Company Financing Transactions

Madison Vaccines Funding Round

Madison Vaccines, operating out of Madison, received $8 million from Venture Investors, State of Wisconsin Investment Board and Venture Management.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series A
Proceeds Purpose
The proceeds will support ongoing development of MVI's pipeline, including completion of an expanded Phase 2 clinical trial for MVI-816 in non-metastatic prostate cancer patients with rapidly rising PSA, before the need for surgical or chemical castration (androgen deprivation therapy or ADT).

Company Information

Company Status
Private & Independent
Mailing Address
505 South Rosa Rd. 201
Madison, WI 53719
Email Address
Not Recorded
The principal mission of Madison, Wisconsin-based MVI is the development of therapeutic plasmid DNA vaccine products for patients with prostate cancer. MVI is also developing a sensitivity test to identify those patients who will derive clinical benefit from these vaccines.
Madison Vaccines LinkedIn Company Profile
Social Media
Madison Vaccines Company Twitter Account
Company News
Madison Vaccines News
Madison Vaccines on Facebook
Madison Vaccines on YouTube

Management Team

Email & Social
Chief Executive Officer
Rick Lesniewski
  Rick Lesniewski LinkedIn Profile  Rick Lesniewski Twitter Account  Rick Lesniewski News  Rick Lesniewski on Facebook
Chief Scientific Officer
Douglas McNeel
  Douglas McNeel LinkedIn Profile  Douglas McNeel Twitter Account  Douglas McNeel News  Douglas McNeel on Facebook



Browse more venture capital transactions:

Prev: 1/14/2014: Chrome River Technologies venture capital transaction
Next: 1/14/2014: Invoca venture capital transaction


Share this article


Where The Data Comes From

We report on all VC transactions involving tech companies. VC transactions reported here come from a variety of public sources. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary